Novel Use of the Proteasome Inhibitor Carfilzomib for Antibody Mediated Rejection After Lung Transplantation

Authors :: Jeffrey J. Teuteberg
J. DʼCunha
Christopher R. Ensor
S.A. Yousem
Christian A. Bermudez
Matthew R. Morrell
M. Shullo
A. Zeevi
John F. McDyer
Joseph M. Pilewski
Source :: Transplantation. 98:806-807
Publication Year :: 2014
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2014.

Subjects :: Transplantation
chemistry.chemical_compound
chemistry
business.industry
medicine.medical_treatment
Antibody mediated rejection
Proteasome inhibitor
medicine
Cancer research
Lung transplantation
business
Carfilzomib
medicine.drug

Tools